关键词: Acute coronary syndrome Antiagrégant plaquettaire Antiplatelet Bleeding Elderly Ischaemic Ischémie Saignement Sujet âgé Syndrome coronaire aigu

Mesh : Acute Coronary Syndrome / blood drug therapy physiopathology Age Factors Aged Aged, 80 and over Anticoagulants / adverse effects therapeutic use Blood Coagulation / drug effects Blood Platelets / drug effects metabolism Clinical Decision-Making Comorbidity Female Fibrinolytic Agents / adverse effects therapeutic use Health Status Hemorrhage / chemically induced Humans Male Platelet Aggregation Inhibitors / adverse effects therapeutic use Risk Assessment Risk Factors Treatment Outcome

来  源:   DOI:10.1016/j.acvd.2020.12.002   PDF(Sci-hub)

Abstract:
Elderly patients represent a growing proportion of the acute coronary syndrome population in Western countries. However, their frequent atypical symptoms at presentation often lead to delays in management and to misdiagnosis. Furthermore, their prognosis is poorer than that of younger patients because of physiological changes in platelet function, haemostasis and fibrinolysis, but also a higher proportion of comorbidities and frailty, both of which increase the risk of recurrent thrombotic and bleeding events. This complex situation, with ischaemic and haemorrhagic risk factors often being intertwined, may lead to confusion about the required treatment strategy, sometimes resulting in inadequate management or even to therapeutic nihilism. It is therefore critical to provide a comprehensive overview of our understanding of the pathophysiological processes underlying acute coronary syndrome in elderly patients, and to summarise the results from the latest clinical trials to help decision making for these high-risk patients.
摘要:
暂无翻译
公众号